Home
Leading the World in Natural Product Discovery
Research › Assay Development

Assay Development

  MerLion Pharma has extensive expertise for developing targets into robust and reproducible high throughput screens. We utilise the full range of miniaturised assay formats, with particular emphasis on homogeneous, fluorescence-based systems. We also have access to cloning, recombinant expression and protein purification capabilities.

 

  • Home
  • About Us
    • Who We Are
    • Board of Directors
    • Management
    • Investors
    • Awards
    • The MerLion
  • Research
    • Natural Product Collections
    • Discovery Biology
    • Natural Product Chemistry
    • Bioprocessing
  • Our Services
    • Extract & Compound Supply
      • Pure Compounds
      • Natural Product Supersets
      • Extract Libraries
    • Screening & Assay Development
      • High Throughput Screening
      • Antimicrobial and Cytotoxicity Testing
      • Assay Development
    • Chemistry & Analytical
      • Fractionation of Extracts
      • Isolation of Natural Products
      • Chemical Structure Elucidation
      • Sample Characterisation by HPLC/UV/MS
      • Sample Characterisation by 1H qNMR
      • Chemical Fingerprinting of Extracts
    • Fermentation & Taxonomic
      • Microbial Fermentation
      • Strain and Process Optimisation
      • Molecular Strain Identification
    • Enquiry
  • Development
    • Finafloxacin
    • Programmes for Licensing
  • News & Publications
    • Press Releases
    • Scientific Publications
    • Presentations and Posters
    • Subscribe to News
  • Contact Us

Copyright © 2009 MerLion Pharma. All Rights Reserved.